Reyad Dada

Publication Activity (10 Years)

Years Active: 2018-2023
Publications (10 Years): 9

Top Topics

Randomized Controlled Trial

Replacement Therapy

Hodgkin Lymphoma

Hematopoietic Stem Cell

Top Venues

Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners

European journal of haematology

Annals of hematology

This page only lists publications with an associated author ORCID identifier.

Publications

Reyad Dada
Redefining Precision Management of r/r Large B-Cell Lymphoma: Novel Antibodies Take on CART and BMT in the Quest for Future Treatment Strategies. Cells 12 (14) (2023)
Reyad Dada
Understanding the differences in outcome between CART studies as second-line treatment in aggressive lymphoma. Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners (2022)
Reyad Dada, Ehab Mosaad Abdelghani, Tarek Boubakra, Jaweed Vayani, Osama Yousof, Emily L Goldman Heaphy, Azhar Nawaz
Outpatient fractionated ICE protocol in relapsed/refractory lymphomas: Efficacy and safety. Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners (2021)
Jamal Zekri, Azhar Nawaz, Haleem Rasool, Imran Ahmad, Hossam Abdel Rahman, Reyad Dada, Ehab Mosaad Abdelghany, Kamel Farag, Refaei Belal Ibrahim, Mohamed Youssef Deibas, Mohamed Kamal Kamel, Ahmed Allithy
Impact of granulocyte-colony stimulating factor on docetaxel-induced febrile neutropenia in patients with breast cancer. Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners (2021)
Reyad Dada
Diagnosis and management of follicular lymphoma: A comprehensive review. European journal of haematology 103 (3) (2019)
Reyad Dada, Yazeed Zabani
Nivolumab induces impressive responses in relapsed/refractory classic Hodgkin lymphoma: Single institutional experience. Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners 25 (7) (2018)
Reyad Dada
Does oncology research need to slow down a little bit? Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners 25 (1) (2018)
Reyad Dada
Program death inhibitors in classical Hodgkin's lymphoma: a comprehensive review. Annals of hematology 97 (4) (2018)
Reyad Dada, Binyam Usman
Allogeneic hematopoietic stem cell transplantation in r/r Hodgkin lymphoma after treatment with checkpoint inhibitors: Feasibility and safety. European journal of haematology 102 (2) (2018)